The University Of Texas Health Science Center At Houston Institutional Biosafety Committee Minutes
The committee reviewed various research protocols involving recombinant or synthetic nucleic acid molecules, including new protocol reviews for neuroinflammation, antibiotic therapy, and depression research. Several conditionally exempt protocols were acknowledged. Significant updates to existing protocols were approved, involving changes in personnel, bioagents, or scope of work for studies on gene expression, Alzheimer's disease, and bacterial treatments. The committee also reviewed administrative items, including the status of annual review forms, biological safety program activity reports, and environmental protection program reports. Other discussions included follow-up on specific facility usage, safety consultations regarding autopsy procedures, and updates on BSL-2 capacity for future research.